Post Ariad: Written Descriptions For Patents
In Ariad Pharmaceuticals Inc. v. Eli Lilly and Company (Ariad), the Court of Appeals for the Federal Circuit confirmed the existence of a written description requirement separate from the enablement requirement....To view the full article, register now.
Already a subscriber? Click here to view full article